BNP Paribas Financial Markets’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,153
Closed -$5.66K 4393
2016
Q4
$5.66K Sell
1,153
-190
-14% -$973 ﹤0.01% 3661
2016
Q3
$6.66K Buy
1,343
+565
+73% +$2.89K ﹤0.01% 3326
2016
Q2
$3.96K Buy
778
+589
+312% +$3.17K ﹤0.01% 3353
2016
Q1
$1.08K Sell
189
-3,529
-95% -$24.6K ﹤0.01% 2497
2015
Q4
$38.6K Sell
3,718
-444
-11% -$6.03K ﹤0.01% 2983
2015
Q3
$76.9K Buy
4,162
+2,575
+162% +$49.7K ﹤0.01% 2558
2015
Q2
$30.9K Buy
1,587
+1,141
+256% +$20.2K ﹤0.01% 2777
2015
Q1
$7.84K Buy
+446
New +$7.49K ﹤0.01% 2887
2014
Q4
Sell
-1,249
Closed -$15.7K 4167
2014
Q3
$15.7K Buy
1,249
+1,240
+13,778% +$17.7K ﹤0.01% 3332
2014
Q2
$141 Sell
9
-98
-92% -$1.44K ﹤0.01% 3737
2014
Q1
$1.52K Sell
107
-189
-64% -$2.96K ﹤0.01% 2746
2013
Q4
$4.76K Buy
+296
New +$4.72K ﹤0.01% 3128

Other funds holding OSIR

BNP Paribas Financial Markets's OSIR Position: Q1 2017 in Review

BNP Paribas Financial Markets sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 1,153 shares — an estimated $5.66K sold.

BNP Paribas Financial Markets first reported a position in OSIR in Q4 2013 and held it in 12 quarters. The position peaked at $76.9K in Q3 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • BNP Paribas Financial Markets reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,153 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $5.66K.
  • BNP Paribas Financial Markets first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2013 and held it in 12 quarters.
  • BNP Paribas Financial Markets's Osiris Therapeutics, Inc. Common Stock position peaked at $76.9K in Q3 2015.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2017, filed 3 May 2017.